Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Explore Our Diverse Range Of Offerings
From detailed reports to experts services offered in 15+
Industry Domains
Add 2 More Reports For 20% off
Report Overview
The global arrhythmia monitoring devices market was valued at USD 9.09 Billion in 2025, driven by the increasing prevalence of cardiovascular diseases across the globe. The market is expected to grow at a CAGR of 7.10% during the forecast period of 2026-2035, with the values likely to reach USD 18.05 Billion by 2035.
Key Market Trends and Insights
- The incidence of cardiovascular disorders, such as arrhythmia, rises with aging populations. As older people are more likely to experience cardiac irregularities, the demand for monitoring devices is witnessing a significant upsurge.
- Real-time arrhythmia detection is made simpler by ongoing advancements in wearable technology and AI-powered monitoring systems, which enhance patient outcomes and boost market growth.
- The demand for arrhythmia monitoring devices as part of preventive healthcare strategies has increased as people become more conscious of the significance of proactively monitoring their heart health.
Market Size and Forecast
- Market Size in 2025: USD 9.09 Billion
- Projected Market Size in 2035: USD 18.05 Billion
- Compound Annual Growth Rate (CAGR) of 2026 to 2035: 7.10%
Compound Annual Growth Rate
7.1%
Value in USD Billion
2026-2035
Arrhythmia Monitoring Devices Market Overview
Arrhythmia monitoring devices are especially designed to detect and treat irregular heartbeats such as bradycardia, tachycardia, or atrial fibrillation. These devices, which give vital information to medical professionals for diagnosis and treatment, might include wearables, implantable loop recorders, and event monitors. They are essential for avoiding consequences from untreated arrhythmias, such as heart failure or stroke.
The market is primarily aided by the trend towards at-home healthcare, especially in the wake of the pandemic and has increased the demand for lightweight, easily navigable arrhythmia monitoring devices that let patients keep an eye on their condition away from medical facilities.
Arrhythmia Monitoring Devices Market Growth Drivers
Innovative Product Launches are Affecting the Market Landscape Significantly
The market for arrhythmia monitoring devices is growing because of new product launches that offer cutting-edge features like enhanced patient connectivity, AI-driven diagnostics, and real-time monitoring. By improving arrhythmia detection accuracy, these advancements enable earlier intervention and better patient outcomes. Companies' market reach is further extended by meeting the growing demand for wearable and minimally invasive solutions as they release increasingly advanced devices. For instance, in July 2020, Medtronic got FDA clearance for its newest product Linq II with AI-powered algorithms. This implantable loop recorder can continuously monitor cardiac rhythms and notify healthcare providers automatically when abnormalities arise. Real-time arrhythmia detection is made possible by the device's remote monitoring capabilities, which allow for early intervention without the need for recurrent hospital visits.
Arrhythmia Monitoring Devices Market Trends
AliveCor announced peer-reviewed results from the M-KEEPS study, showing that 30-day, patient-initiated monitoring with its KardiaMobile 6L detected significantly more clinically important arrhythmias than conventional short-duration ambulatory ECG monitoring alone. The handheld device provides six-lead ECG recordings that can be triggered when patients experience symptoms. The study supports the use of extended, symptom-triggered monitoring for detecting intermittent rhythm abnormalities that may not appear during shorter monitoring periods. The findings strengthen demand for portable, patient-initiated ECG devices capable of extending arrhythmia monitoring beyond conventional short-duration testing.
RhythMedix launched the third-generation RhythmStar SL cardiac monitoring wearable, introducing improvements aimed at comfort, adherence and remote data transmission. The device features a more compact lead configuration, IPX6 water resistance and increased battery life. Its built-in cellular connectivity automatically transmits ECG data to the cloud, allowing monitoring information to reach clinical teams without requiring patients to return the device for data processing. The launch is advancing wearable cardiac monitoring toward more convenient, connected devices that can support continuous remote arrhythmia assessment.
HeartBeam unveiled a working prototype of an extended-wear 12-lead ECG patch designed for ambulatory cardiac monitoring. The patch continuously records cardiac rhythms using a single lead and allows patients to obtain an on-demand 12-lead ECG by interacting with the device. HeartBeam is combining its 3D ECG technology with AI and clinical expertise from Mount Sinai. The company subsequently began a pilot study evaluating the patch in high-risk patients. The development could broaden ambulatory monitoring by combining continuous rhythm tracking with on-demand multi-lead ECG assessment in a wearable format, thus boosting the trends of the arrhythmia monitoring devices market.
AliveCor received FDA clearance for five additional cardiac determinations through the KAI 12L artificial-intelligence system powering its Kardia 12L ECG System. The additions included Short PR Interval, Atrial Bigeminy, Ventricular Bigeminy, Left Axis Deviation and Right Axis Deviation, bringing the system’s total number of cleared determinations to 39. The handheld Kardia 12L provides a portable 12-lead ECG through a single-cable design. Expanded AI-based ECG interpretation is increasing the diagnostic capabilities of portable arrhythmia-monitoring devices and supporting their use beyond basic rhythm detection.
AI Is Moving Toward Continuous Arrhythmia Risk Analysis
Artificial intelligence is moving beyond simple ECG classification toward continuous analysis of long-duration rhythm data. Newer approaches are designed to examine changes across extended ECG recordings and identify patterns that may precede clinically important events. Some research from 2026 has studied AI-based ECG age as an indicator of the presence and degree of atrial fibrillation, and other research is investigating ECG patterns over time for early warning of rhythm abnormalities. This is especially relevant for Holter monitors and other wearable ECG devices, which produce massive amounts of continuous data. Rather than asking doctors to manually analyze all recorded data segments, AI can focus attention on possibly problematic periods of the recordings. AI-enabled analysis is increasing the value of arrhythmia monitors by improving automated screening, prioritisation and interpretation of lengthy ECG recordings.
Wearable ECG Monitoring Is Moving Into Longer-Term Use
Arrhythmia monitoring is increasingly shifting from short clinical measurements toward longer-duration wearable monitoring that captures cardiac rhythms during patients’ normal daily activities. Wearable ECG patches, smartwatches and other small gadgets are capable of collecting longitudinal data beyond hospital settings, possibly enhancing the chances of detecting intermittent arrhythmias that may not be present during a normal ECG screening process. According to a European Heart Journal review of 2026, the growing use of wearable gadgets for longitudinal cardiovascular monitoring was noted along with the requirement of better clinical workflow and validation. Research conducted at the Heart Rhythm conference of 2026 showed the effectiveness of wearable gadgets over traditional ambulatory patches for children’s arrhythmia detection. Longer monitoring periods are supporting demand for wearable ECG patches, compact monitors and devices designed for continuous ambulatory rhythm assessment, thereby augmenting the growth of the arrhythmia monitoring devices market.
Cloud Connectivity Is Becoming Integral to Remote Monitoring
Arrhythmia-monitoring devices are increasingly being designed as connected systems rather than standalone recording equipment. Wireless communication enables ECG recordings made by devices at home or during day-to-day activity to be transmitted to the healthcare professionals who will analyze them from a distance, eliminating the need for returning the recording device just in order to transmit the data stored in it. Emerging trends on the market include integration of wearables with cloud services, remote dashboarding and analysis. Such an approach is very helpful when it comes to prolonged monitoring, as huge amounts of ECG recordings can be sent for further analysis. Connected monitoring is expanding the addressable market for wireless ECG patches, cloud-based cardiac platforms and remote patient-monitoring services.
Multimodal Sensors Are Improving Rhythm Monitoring
Arrhythmia monitoring is increasingly exploring combined ECG and other physiological signals rather than depending on a single measurement. ECG provides direct information on the heart’s electrical activity, while photoplethysmography (PPG), motion sensors and other signals can provide complementary information about pulse and physiological conditions. Current studies are looking into the adaptive ECG-PPG fusion method that will enable continued functionality in case there is motion artifacts in one of the two signals. This is especially true in cases where sensors are utilized in devices worn outside the controlled setting of a hospital where movement and inaccurate sensor placement may affect the recording process. By integrating signals, device makers can solve the problem posed by continuous monitoring, which is the maintenance of data integrity during movement. Multisensor monitoring can improve signal reliability and strengthen the capabilities of wearable arrhythmia devices used for continuous real-world monitoring.
ECG Devices Are Becoming More Capable of Supporting Early Detection
Arrhythmia-monitoring technology is increasingly being developed to extract more clinical information from routine ECG recordings, rather than limiting devices to basic heart-rate or rhythm measurements. In August 2026, researchers reported an AI system capable of identifying signs of heart failure and valve disease from routine ECG data in seconds, demonstrating how AI can expand the diagnostic information obtained from existing ECG infrastructure. Although these conditions extend beyond arrhythmia itself, the development illustrates the broader direction of ECG technology toward multifunctional analysis. Similar approaches could allow future monitoring devices to identify multiple cardiovascular risk signals from the same recording, increasing the clinical value of ambulatory ECG systems. Broader ECG analytics can increase the clinical utility of arrhythmia-monitoring devices and encourage demand for AI-enabled systems capable of detecting multiple cardiovascular abnormalities.
Arrhythmia Monitoring Devices Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Devices
- Event Monitoring Devices
- Continuous Rhythm Monitoring Devices
- Holter Monitoring Devices
- Others
Market Breakup by Application
- Atrial Fibrillation
- Bradycardia
- Atrial Flutter
- Tachycardia
- Ventricular Fibrillation
- Others
Market Breakup by End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
- Academic and Research Laboratories
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Arrhythmia Monitoring Devices Market Share
The Continuous Rhythm Monitoring Devices Segment Holds a Significant Market Share
The market segmentation by devices is divided into event monitoring devices, continuous rhythm monitoring devices, Holter monitoring devices, and others. These devices are made to monitor cardiac rhythms for extended periods of time, frequently in real-time, to identify anomalies like arrhythmias. They are usually utilized with Holter monitors or wearable ECG devices for patients who need continuous cardiac monitoring. The early detection of transient or intermittent arrhythmias that may go unnoticed during routine checks is improved by continuous monitoring.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Purchase the Regional Overview for USD 1099
If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.
Arrhythmia Monitoring Devices Market Analysis by Region
Regionally, North America is expected to dominate the market during the forecast period. This can primarily be attributed to the rise in the prevalence of cardiovascular disorders along with the growth in aging population in the region. The United States holds a significant share in the North American region, owing to factors such as a high patient pool for major chronic cardiac diseases. Additionally, the presence of major players, early adoption of technologically advanced products, and an increase in research and development activities are expected to propel regional growth in the forecast period.
Leading Players in the Arrhythmia Monitoring Devices Market
The key features of the market report comprise the patent analysis, funding and investment analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Abbott
Founded in 1888, Abbott is headquartered in Abbott Park, Illinois, it is a multinational healthcare corporation with expertise in the creation of branded generic medications, medical devices, diagnostics, and nutrition products. It is a major player in the market for arrhythmia monitoring, offering cutting-edge devices such as implantable cardiac monitors.
Medtronic plc
Founded in 1949, Medtronic has its headquarters in Dublin, Ireland. A well-known international manufacturer of medical technology, the company creates and produces cutting-edge products including sophisticated arrhythmia monitoring solutions like implantable loop recorders and remote monitoring systems. The company uses state-of-the-art cardiac monitoring technologies with the goal of improving patient care.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include ACD Diagnostics, GE Healthcare, Koninklijke Philips N.V., BIOTRONIK SE & Co. KG, Zio by iRhythm Technologies, Inc., FUKUDA DENSHI CO., LTD., AliveCor, Inc., and SPACELABS HEALTHCARE SOLUTIONS PRIVATE LIMITED.
Key Questions Answered in the Arrhythmia Monitoring Devices Market Report
- What was the global arrhythmia monitoring devices market value in 2025?
- What is the global arrhythmia monitoring devices market forecast outlook for 2026-2035?
- What are the regional markets covered in the EMR report?
- What is market segmentation based on devices?
- What is the market breakup based on application?
- Who are the major end users in the market?
- What are the major factors aiding the global arrhythmia monitoring devices market demand?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- How do the prevalence and incidence of chronic diseases affect the market landscape?
- What are the major global Arrhythmia Monitoring Devices market trends?
- How does the rise in the geriatric population impact the market size?
- Which product type will dominate the market share?
- Which application is expected to have a high market value in the coming years?
- Which end user is projected to contribute to the highest market growth?
- Who are the key players involved in the arrhythmia monitoring devices market?
- What is the patent landscape of the market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Pricing Plans
Upto 15% Off
USD
-
$3299 $2969
-
$5499 $4949
-
$6999 $5949
-
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Report Summary
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Devices |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
- Selected Segments
- Printing Restrictions
- Excel Spreadsheet Delivered via Email
- Full Report
- Periodic Updates
- Post Sales Analysts Support
- Unlimited Prints
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
- All Segments
- Printing Restrictions
- PDF Delivered via Email
- Custom Report Layout
- Post Sales Analysts Support
- Periodic Updates
- Unlimited Prints
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
- All Segments
- Five Prints Available
- PDF Delivered via Email
- Limited Free Customization
- Post Sales Analyst Support
- Custom Report Layout
- Periodic Updates
- Unlimited Prints
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
- All Segments
- Unlimited Prints Available
- PDF & Excel Delivery via Email
- Limited Free Customization
- Post Sales Analysts Support
- Discount On Next Update
- Custom Report Layout
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Bundle Type
Flash Bundle
20% OFF
Number of Reports: 3
Small Business Bundle
25% OFF
Number of Reports: 5
Growth Bundle
30% OFF
Number of Reports: 8
Enterprise Bundle
35% OFF
Number of Reports: 10
Overview
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 80 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
- Life Time Access
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 100 Hours
- Complimentary Free 1 Month Subscription to Trade Data Base
- Complimentary One Month Subscription to Price Database (Chemicals only)
- Complimentary PPT Version of the Report
- Complimentary License Upgrade
- Complimentary Power BI Dashboards
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
- 3 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
- Free Analyst Hours
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
- 5 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- Complimentary Excel Data Set
- PPT Version of the Report
- Power BI Dashboards
- License Upgrade
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
- 8 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Free Analyst Hours - 80 Hours
- Power BI Dashboards
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
- 10 Reports Included
- Life Time Acess
- Analyst Support Related to Report
- PDF Version of the Report
- Complimentary Excel Data Set
- Free Analyst Hours - 50 Hours
- Free 1 Month Subscription to Trade Data Base
- 1 Month Subscription to Price Database (Chemicals only)
- License Upgrade
- Power BI Dashboards
- Free Analyst Hours - 100 Hours
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
